The next controversy in genetic testing: clinical data as trade secrets?

Sole-source business models for genetic testing can create private databases containing information vital to interpreting the clinical significance of human genetic variations. But incomplete access to those databases threatens to impede the clinical interpretation of genomic medicine. National heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook-Deegan, Robert, Conley, John M, Evans, James P, Vorhaus, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658186/
https://www.ncbi.nlm.nih.gov/pubmed/23150081
http://dx.doi.org/10.1038/ejhg.2012.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658186/
https://www.ncbi.nlm.nih.gov/pubmed/23150081
http://dx.doi.org/10.1038/ejhg.2012.217

Ejemplares similares